TLDR: A comparative study on AI adoption in veterinary medicine across China and North America reveals an “adoption paradox.” Chinese professionals, despite lower familiarity, show higher AI adoption, primarily for clinical tasks like diagnosis and prescription calculation. North American professionals, with higher familiarity, exhibit lower adoption, focusing more on administrative functions such as imaging analysis and record-keeping. These differences are attributed to regional factors including workforce demographics, educational structures, and market maturity, underscoring the need for tailored AI development and integration strategies globally.
Artificial intelligence (AI) is rapidly transforming various sectors, and veterinary medicine is no exception. A recent comparative analysis, titled “The Adoption Paradox: A Comparative Analysis of Veterinary AI Adoption in China and the North America”, sheds light on how AI is being embraced by veterinary professionals in China and North America, revealing distinct regional pathways.
The study, conducted by Shumin Li and Xiaoyun Lai, aimed to compare the perceptions, adoption rates, and application priorities of AI among veterinary professionals in these two major markets. It hypothesized that adoption patterns are significantly influenced by regional market and demographic factors, and the findings strongly support this idea.
The Adoption Paradox Unveiled
One of the most striking discoveries is what the authors term the “adoption paradox.” The Chinese cohort, consisting of 455 veterinary professionals surveyed from May to July 2025, showed relatively low AI familiarity (55.4%) but a remarkably high adoption rate (71.0%). In contrast, the North American cohort, based on a 2024 survey of 3,968 professionals from the United States and Canada, reported high familiarity (83.8%) but a lower adoption rate (39.2%).
This paradox suggests that while North American professionals are more aware of AI, Chinese professionals are more actively integrating it into their daily work, even with less initial familiarity.
Divergent Application Priorities
The study found significant differences in how AI is being applied in each region. Chinese veterinary professionals primarily use AI for clinical tasks. The most common applications include AI-assisted disease diagnosis (50.1%) and prescription calculation (44.8%). This indicates a “practitioner-driven, bottom-up” adoption model, where AI augments clinical efficacy.
Conversely, North American professionals prioritize administrative functions. Their top AI applications involve imaging analysis (39.0%) and record-keeping (39.0%). This reflects a more “structured, top-down” integration aimed at improving administrative efficiency.
Understanding the Regional Drivers
These differing approaches are largely shaped by the unique characteristics of each region’s veterinary ecosystem. The Chinese cohort was predominantly composed of frontline clinicians (81.5%), many of whom are early-to-mid-career professionals. Their educational background, often a bachelor’s or associate degree, and potentially limited access to specialized expertise, drive the use of AI as a powerful tool to bridge knowledge gaps and standardize care quality. For them, AI acts as a digital decision support system.
In North America, veterinary medicine is a postgraduate profession requiring a doctoral degree, supported by a robust network of specialists. The workforce is more diverse, including managers and support staff. For this highly trained group, operational and administrative bottlenecks are often the primary challenges, making AI integration for efficiency gains and cost savings a logical first step.
Barriers to Adoption: Universal and Regional
While concerns about AI reliability and accuracy were the top barrier in both groups (NA: 70.3%, China: 54.3%), other obstacles varied significantly. North American professionals expressed greater concerns about data security and privacy (53.9% vs. 26.6% in China), cost of implementation (42.6% vs. 20.4% in China), and fear of job displacement (36.1% vs. 20.9% in China). These concerns reflect a more mature market actively evaluating commercial AI products.
In China, the primary barriers were a lack of training and knowledge (49.5%) and insufficient AI tool options (36.0%). This suggests the Chinese market is at a more foundational stage, with a demand for more specialized veterinary AI products and the necessary education to use them effectively.
Also Read:
- Mapping the Landscape of Human–AI Trust in Generative AI
- How AI Reshapes Global Competitiveness: Insights from China and the US
Implications for the Future
The study concludes that a one-size-fits-all approach to AI development and integration in veterinary medicine is inadequate. Tailored, region-specific strategies are essential for technology design, professional education, and regulatory oversight. Ethical considerations, such as liability, data privacy, and the potential for skill degradation due to over-reliance on technology, are also highlighted as urgent needs for clear frameworks.
Ultimately, AI should be viewed as an assistant that frees professionals from repetitive tasks, allowing them to focus on uniquely human skills like surgery and empathetic communication, thereby elevating their role as high-level, AI-augmented clinical decision-makers.
